SparingVision Conference Participation in H2 2023
Paris, September 7, 2023 – SparingVision (“the Company”), a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, today announces upcoming conferences that its management team will be participating in in the second half of 2023:
Investor and Industry Conferences:
Morgan Stanley 21st Annual Healthcare Conference, New York City, New York, US – 11-14 September
Sachs 23rd Annual Biotech in Europe Forum, Basel, Switzerland – 20-21 September
Chardan’s 7th Annual Genetic Medicines Conference, New York City New York, US – 2-3 October
Cell and Gene Meeting on the Mesa, Carlsbad, California, US – 10-12 October
Jefferies London Healthcare Conference, London, UK – 14-15 November
Scientific, Medical & Regulatory Conferences:
Johns Hopkins Retinal Degenerations and Clinical Electrophysiology Conference 2023, Baltimore, Maryland, US – 15-16 September
4th Annual Gene Therapy for Ophthalmic Disorders Conference, Boston, Massachusetts US – 3-5 October
EURETINA (European Society of Retina Specialists) Congress, Amsterdam, Netherlands – 5-8 October
2023 TOPRA Annual Symposium, Lisbon, Portugal – 23-25 October
RD 2023, Torremolinos, Spain – 23-28 October
ESGCT (European Society of Gene and Cell Therapy) 30th Annual Congress, Brussels, Belgium – 24-27 October
Eyecelerator @ AAO, San Francisco, California, US – 2 November
American College of Toxicology Annual Meeting, Orlando, Florida, US – 12-15 November
Ophthalmic Drugs, London, UK – 20-21 November
**ENDS**